Added to YB: 2024-09-19
Pitch date: 2024-09-17
TEVA [bullish]
Teva Pharmaceutical Industries Limited
+66.61%
current return
Author Info
Kontra Investment Xchange is trying to build wealth by investing in good companies and letting those investments compound over many years. Sign up for the newsletter.
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$30.7B
Pitch Price
$17.88
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.65
P/E
43.30
EV/Sales
2.72
Sector
Pharmaceuticals
Category
growth
Update on Teva: Long term is still Bullish
TEVA: Cautiously optimistic on long-term prospects. Strong brand growth (Austedo $2.5B by 2027), expanding LAIs, underestimated pipeline (TL1a w/ Sanofi, ICS/SABA), stable generics. Risks: litigation, regulatory changes. Deleveraging ongoing. 2027 goals on track. Mgmt proactive under Schultz.
Read full article (3 min)